A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)
Clinical trial NCT07593144 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07593144
- Sponsor
- Foresight Therapeutics (Hefei) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2029-01-15
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.